Gary Alter, Acclaimed Plastic Surgeon, Travels to Chile for Reconstructive Surgery Congress

Dr. Gary Alter, Acclaimed Plastic Surgeon

Dr. Alter recently travelled to Chile to be a guess faculty speaker at the 2019 Chilean Plastic and Reconstructive Surgery Congress in Santiago, Chile.

LOS ANGELES, CA, UNITED STATES, August 30, 2019 /EINPresswire.com/ — Dr. Gary Alter, acclaimed plastic surgeon, has had an incredibly busy year so far. Between teaming up with the Stem Cell Doctors of Beverly Hills to open his new state-of-the-art Biocellular Center, (https://stemcelldoctorsbeverlyhills.com/), he also recently travelled to Chile to be a guess faculty speaker at the 2019 Chilean Plastic and Reconstructive Surgery Congress in Santiago, Chile, which took place August 8-10, 2019.

“It was an amazing experience,” explains Dr. Alter, “I spoke on topics such as ‘buried penis’, ‘female genital aesthetic surgery including reconstruction of botched labiaplasties,’ ‘male to female gender confirmation surgery,’ ‘reconstruction of deformities from penile enlargement surgery,’ and ‘scrotum reduction.’” "The plastic surgeons were very gracious and interested in my work."

Dr. Gary Alter is an American plastic surgeon. His specialties include male and female genital reconstruction and gender confirmation surgery. He appeared in multiple episodes of the reality television series, "Dr. 90210" and one episode of “Botched”, both on the E! television network. He currently has an acclaimed practice in Beverly Hills, CA and Manhattan, NY.

Dr. Alter was the second surgeon ever with board certification by both the American Board of Plastic Surgery and the American Board of Urology. He is an Assistant Clinical Professor of Plastic Surgery at UCLA School of Medicine. Dr. Alter performs most cosmetic plastic surgical procedures, but his sub-specialty is in genital aesthetic and reconstructive surgery. He has invented many original surgical procedures adopted by other surgeons worldwide, including the "Alter Central Wedge labiaplasty technique".

The acclaimed doctor has been highlighted on Alexis Arquette: She's My Brother (documentary) and on the TLC show Strange Sex, discussing hidden penis syndrome. He has appeared on the Discovery Health Network, TLC, CNN, the Larry King Show, and was a recurrent guest on "Red Eye" on the Fox News Channel. He has also been featured in numerous media outlets including the New York Times, the Los Angeles Times, the Wall Street Journal, USA Today, Allure, Self, Glamour, Marie Claire, Cosmopolitan, and Health.

“My trip to Chile was an enriching experience,” concludes Dr. Alter, “I will continue traveling and speaking worldwide to share my knowledge about my unique procedures.”

Aurora DeRose
Michael Levine Media
+1 310-396-6090
email us here


Source: EIN Presswire

Global Healthcare Rigid Packaging Market 2019 Share, Trend, Segmentation and Forecast to 2025

Healthcare Rigid Packaging Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025

PUNE, MAHARASHTRA, INDIA, August 30, 2019 /EINPresswire.com/ — Healthcare Rigid Packaging Market 2019

Wiseguyreports.Com adds “Healthcare Rigid Packaging Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.

Report Details:

This report provides in depth study of “Healthcare Rigid Packaging Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Healthcare Rigid Packaging Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The report offers an in-depth analysis by analyzing the trends that are shaping the industry. The report provides a comprehensive investigation of the market structure along with an estimate for the upcoming years of various segments and sub-segments of the Healthcare Rigid Packaging market. The factors controlling the Healthcare Rigid Packaging market are accurately profiled in the report. The inclusion of the historical data and the forecast of the returns of the Healthcare Rigid Packaging market’s segments and sub-segments concerning regions and their corresponding critical countries. The widespread chief investigation was directed to achieve a deeper insight into the market and the industry presentation. Important data about main players, market classification, and segmentation as per the industry trends, regional markets, & developments connected to the market and technology viewpoints are covered in the scope of the report.

The drivers and constraints of the Healthcare Rigid Packaging market are precisely identified and scrutinized in terms of the effect they have on the overall Healthcare Rigid Packaging market. A number of capacity growth factors, possibilities, and prospects are also gaged to get a grasp on the overall condition of the overall market.

It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Healthcare Rigid Packaging market.

The Leading key players covered in this study 
Amcor 
Bemis Company 
DS Smith 
Huhtamaki 
Berry Global 
Sonoco Products 
Sealed Air Corporation 
Constantia Flexibles Group GmbH 
Winpak 
CCL Industries 
3M 
Dunmore 
Toray Plastics 
WestRock 
Mondi Group 
BillerudKorsnas 
Ball Corporation 
Honeywell International 
Klockner Pentaplast Europe GmbH 
Avery Dennison Corporation

Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4390930-global-healthcare-rigid-packaging-market-insights-forecast-to-2025

This research report categorizes the global Healthcare Rigid Packaging market by top players/brands, region, type and end user. This report also studies the global Healthcare Rigid Packaging market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

Market split by Type, can be divided into: 
Double Bowl 
Single Bowl

Market split by Application, can be divided into: 
Household 
Commercial

Market segment by Region/Country including: 

The regional evaluation of the Healthcare Rigid Packaging market includes an analysis of the regions included in the industry. The regions of Europe, Middle East, Asia Pacific, North America, and Africa. The inclusion of competitive developments such as strategic alliances, joint ventures, mergers and acquisitions, new product developments, and research and developments in Healthcare Rigid Packaging market are expected to provide an even deeper insight into the market. The country-level analysis of the Healthcare Rigid Packaging market is also carried out for segments based on the various segments in the Healthcare Rigid Packaging market.

Key Stakeholders 
Healthcare Rigid Packaging Manufacturers 
Healthcare Rigid Packaging Distributors/Traders/Wholesalers 
Healthcare Rigid Packaging Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@  https://www.wiseguyreports.com/reports/4390930-global-healthcare-rigid-packaging-market-insights-forecast-to-2025

Major Key Points from Table of Content:

Chapter 1 Study Coverage
Chapter 2 Executive Summary
Chapter 3 Market Size by Manufacturers
Chapter 4 Healthcare Rigid Packaging Production by Regions
Chapter 5 Healthcare Rigid Packaging Consumption by Regions
Chapter 6 Market Size by Type
Chapter 7 Market Size by Application
Chapter 8 Asia Pacific
Chapter 8 Manufacturers Profiles 
8.1 Amcor 
8.1.1 Amcor Company Details 
8.1.2 Company Description 
8.1.3 Capacity, Production and Value of Healthcare Rigid Packaging 
8.1.4 Healthcare Rigid Packaging Product Description 
8.1.5 SWOT Analysis 
8.2 Bemis Company 
8.2.1 Bemis Company Company Details 
8.2.2 Company Description 
8.2.3 Capacity, Production and Value of Healthcare Rigid Packaging 
8.2.4 Healthcare Rigid Packaging Product Description 
8.2.5 SWOT Analysis 

Continued….

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Mike Page, Alexion Pharmaceuticals invite to SMi's Orphan Drugs & Rare Diseases Conference

SMi Reports: Mike Page, Executive Director at Alexion Pharmaceuticals invites heads of medical affairs and all interested to SMi’s Orphan Drugs & Rare Diseases

LONDON, GREATER LONDON, UNITED KINGDOM, August 30, 2019 /EINPresswire.com/ — Mike Page will be co-chairing the conference with Rick Thompson, CEO at Findacure, which will be taking place on 15th and 16th October in London.

This conference will bring together a broad spectrum of experts from across the orphan drug world. The two-day compact agenda will offer a series of presentations, through which you will gain key insights into current trends and innovations in orphan drug development, using real world case studies to illustrate challenges and opportunities.

The rare and ultra rare disease landscape is constantly changing as new diagnostic and therapeutic technologies emerge and partnerships are developed to address patient access and funding issues. At the conference, speakers from patient organisations, pharmaceutical R&D companies, health technology assessment groups, and others will lay out the current landscape and address how the orphan drug space will develop as the century continues.

Delegates will gain many invaluable insights from this event, on major topics such as:
• International perspectives on state-of-the-art rare disease research and development
• Patient perspectives on the challenges of navigating the path to diagnosis and encouraging research interest in rare diseases
• Cutting edge innovations with emerging technologies including stem cell therapy and artificial intelligence
• Appraisal of real-world value for new therapies in the orphan drug arena
• Following the conference there will be a half day workshop where delegates will deep dive into strategies for accelerating patient access to orphan drugs, addressing issues, opportunities and barriers, that are met when developing a product for patients with rare diseases.

To view the full details of the 2-day conference agenda, half-day workshop and the expert speaker line-up, please view the brochure available to download online http://www.orphandrugs.co.uk/pr4

For sponsorship and exhibitor enquiries, please contact Alia Malick on on +44 (0) 207 827 6168 or amalick@smi-online.co.uk

SMi’s 9th Annual Orphan Drugs and Rare Diseases 2019
Conference: 15th – 16th October 2019
Workshop: 17th October 2019
London, UK
http://www.orphandrugs.co.uk/pr4
#SMiOrphanDrugs

—- END —-

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
7800890224
email us here


Source: EIN Presswire

Hempure CBD Launches Extensive CBD Tincture Guide

Hempure CBD Tincture Guide

Hempure launches the long-awaited CBD Tincture Guide.

Hempure CBD’s newly released CBD Tincture Guide has all the information you should know before you try CBD drops.

ASHLAND, OREGON, UNITED STATES, August 30, 2019 /EINPresswire.com/ — CBD tinctures – also known as CBD drops – are understandably popular because they’re so versatile. However, most people taking CBD drops don’t know that the many different ways of taking CBD tinctures can sometimes produce very different results. It is with the motive to educate both novices and seasoned CBD users that Oregon-based Hempure CBD has launched a CBD Tincture Guide.

Hempure founder Sabina King says that since most traditional supplements are in the form of capsules or pills, CBD drops can be poorly understood. “There aren’t too many ways that you can experiment with capsules. CBD drops, on the other hand, can be taken under the tongue, mixed in with a drink, or added to food.” King believes that users should feel free to choose the method of ingestion they prefer, but the choice must be made with an understanding of the mechanism of each method.

In the CBD Tincture Guide, one can expect to find information about what a tincture contains, different bioavailability rates for different methods of consumption, and finally, the benefits you can expect from regular use.

The research-based guide contains a plethora of information and follows in the footsteps of the popular Hempure CBD Dosage Guide that was launched a month prior and gives dosing instructions that apply to capsules, CBD vape oil, tinctures and more. One of the company’s missions is to lead with education over marketing gimmicks. “In an industry rife with misinformation, we think it’s exceptionally important to provide credible knowledge so that customers can make the best decision for themselves, and not follow what’s best for a brand.”

So if you’re looking to try CBD, or just interested in knowing more, check out the Hempure CBD Tincture Guide at http://www.hempurecbd.com/cbd-tincture-guide/

Sabina DiBella
Hempure
+1 732-534-5132
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Global Q-TOF Mass Spectrometry Market to Reach 1000 Million USD by 2023

WiseGuyReports.Com Publish a New Market Research Report On –“ Global Q-TOF Mass Spectrometry Market to Reach 1000 Million USD by 2023”.

PUNE, INDIA, August 30, 2019 /EINPresswire.com/ —

Q-TOF Mass Spectrometry Industry 2019

Description:-

Mass Spectrometry is a technique used to measure the mass-to-charge ratio of ions. Invented by Nobel laureate Wolfgang Paul, Quadrupole-Time of Flight or Q-TOF Mass Spectrometry is a type of mass spectrometry where the mass-to-charge ratio of an ion is measured using a time of flight measurement, in which the ions are speeded up by an electric field of pre-determined strength, and the results are displayed as a mass spectrum.

This technique has its uses in several fields such as biochemistry, pharmacokinetics, food safety, drug testing and space exploration to name a few.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3689411-global-q-tof-mass-spectrometry-market-2018-by

For more information or any query mail at sales@wiseguyreports.com

The global Q-TOF Mass Spectrometry market was valued at 700 million USD in 2017 and is expected to reach 1009.7 million USD by the end of 2022, growing at a CAGR of 7.7% between 2017 and 2023.

This report analyzes the status and worldwide scope of the Q-TOF Mass Spectrometry market during the period 2017-2023, outlines the key players, and splits the market by the types of this technique and its applications.

Segmentation:

The key players in the Q-TOF Mass Spectrometry market across the world include the following:
Agilent Technologies
Bruker
Shimadzu Corporation
Waters Corporation
Danaher

Based on the type, this market can be divided into two broad categories, namely Two-Grade and Three-Grade, whereas, based on application, the Q-TOF Mass Spectrometry market is split up across industries such as biotechnology, food and beverage testing, pharmaceuticals, petrochemicals and environmental testing. The growing applications of this technique in these sectors, positive government initiatives, and a larger focus on the production of high-quality products has ensured a steady market growth for this technology, especially in growing economies such as Latin America and the Asia Pacific region.

Regional Analysis:
Based on historical data, market experts predict that the Asia Pacific region will occupy a higher market share in the future forecasted period, with China being a major market, followed by India and South East Asia. However, in terms of market growth, it may be noted that North America will be the market leader, particularly the United States, as any significant change from the US would impact the development of Q-TOF Mass Spectrometry in other markets. Besides, the growth in government funding and increasing research in the biotechnology and pharmaceutical fields in the US are also major drivers for growth of the North American as well as Canadian market. Europe is also estimated to play an important role in the global market.

Industry News:
According to the latest news, the application of the Q-TOF Mass Spectrometry technique will see the highest growth in the field of biotechnology, with biotechnology expected to register the highest CAGR during the forecast period. The downside of this technology is the high costs of the Q-TOF instruments, which are hampering the growth of this market to a certain extent. However, with the United States and Canada getting substantial government grants for research and development, this market is expected to provide ample opportunities for new players.
Complete Report Details @ https://www.wiseguyreports.com/reports/3689411-global-q-tof-mass-spectrometry-market-2018-by

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Rising instances of IBS to cause growth in global irritable bowel syndrome treatment market 2023

WiseGuyReports.Com Publish a New Market Research Report On –“Rising instances of IBS to cause growth in global irritable bowel syndrome treatment market 2023”.

PUNE, INDIA, August 30, 2019 /EINPresswire.com/ —

Irritable Bowel Syndrome Treatment Industry 2019

Description:-

In today’s times, irritable bowel syndrome commonly known as IBS is a global issue. IBS occurs because of functional gastrointestinal disorders. Around 15% of the total world population is experiencing symptoms related to IBS. The ones who are suffering the most are women and people below the age group of 50. This problem is caused when there is an imbalance in the way the brain, nervous system, and gut interact with each other. This cause changes in bowel sensation and movement. The most common symptoms of IBS are stomach pain and distress with altered bowel habits. The global irritable bowel syndrome treatment market is expected to grow in the years to come because of the growing anxiety levels of the people, the prevalence of depression, and strong drug pipeline.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3977552-global-irritable-bowel-syndrome-treatment-market-research-report-forecast-to-2023

For more information or any query mail at sales@wiseguyreports.com

Key Players

Abbott, Allergan Inc., Ardelyx, Inc., Astellas Pharma, Inc., Ironwood Pharmaceuticals, Lexicon Pharmaceuticals, Inc., Mallinckrodt, Nestle Health Science, Synergy Pharmaceuticals Inc., and Valeant Pharmaceuticals International, Inc.
As per the report found on Wise Guy Report (WSR), the global irritable bowel syndrome treatment market is expected to reach a market value of $2,988.6 million by the end of 2023. The market is expected to register a CAGR of 7.58% during the forecast period. The market is driven by the rising prevalence of the target disease along with the increasing uptake of drugs for the same. Also, the rising commercialization of the drugs will accelerate the growth in the forecast period.

Various pharmaceutical companies are working on some promising products which are currently under clinical trials. These products will address the unmet needs of people in this therapy area, which will further accelerate the growth.

Segmentation:
The global irritable bowel syndrome treatment market is segmented based on type, drug type, and end user. Such insights allow the market players to develop strategies and develop medicines for the treatment of this global problem.

Based on the type, the global irritable bowel syndrome treatment market is classified into IBS-D, IBS-C, and IBS-M. The largest market share at a CAGR of 8.31% is claimed by IBS-D.
Based on the drug type, the global irritable bowel syndrome treatment market is segmented into lubiprostone, linaclotide, eluxadoline, rifaximlin, alosetron, and others. The linaclotide segment accounted for the largest market share at a CAGR of 7.95%.

Based on the end user, the global irritable bowel syndrome treatment market is segmented into hospitals, research laboratories, clinics, and others. The largest market share is taken by hospitals at a CAGR of 8.04%.

Regional Analysis:
America (both North and South), Asia Pacific, Europe, and the Middle East & Africa are considered as the key regions as per the regional analysis of the global irritable bowel syndrome treatment market.
As per the data of the previous years, the United States held the highest share of the global irritable bowel syndrome treatment market followed by Europe and then the Asia Pacific region. By 2023, America is expected to grow at a CAGR of 8.69%.

Industry News:
In 2019, Linzess was approved in China. This is expected to give the global irritable bowel syndrome treatment market a boost. Japan noticed significant growth because of Linzess.

Complete Report Details @ https://www.wiseguyreports.com/reports/3977552-global-irritable-bowel-syndrome-treatment-market-research-report-forecast-to-2023

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Huge Demand of PVD Medical Device Market 2019-2025-Size,Share,Trend,Growth,Growth rate Application,Regional Trend

Wiseguyreports added new comprehensive Analysis Report “PVD Medical Device Market 2019-2025” to its huge database.

PUNE , MAHARASHTRA , INDIA , August 30, 2019 /EINPresswire.com/ — The PVD Medical Device Market study of the global market was undertaken by using a combination of primary as well as secondary research methodologies. The report comprises key information about the market in both quantitative and qualitative manner. The qualitative side of the analysis includes various projection and sampling methodologies. On the other hand, quantitative analysis of the market includes surveys, expert opinions, primary level interviews, vendor briefings, and others.

Drivers and Constraints
The report covers a thorough analysis of significant factors that impact the PVD Medical Device market significantly. The report precisely explains the factors that are challenging, driving, and restraining the market growth over the evaluation period. It also comprises the dynamics that are expected to create probable opportunities for market players to attain an inclusive understanding of the market.

Try Free Sample Report @ https://www.wiseguyreports.com/sample-request/4381483-global-pvd-medical-device-market-report-2019-market

Key Players

The report contains a complete study of the competitive scenario of the PVD Medical Device Market and the existing trends that are anticipated to impact the market. It recognizes vital players of the market, including both key and emerging players. The report consists of the companies in the market share study to offer a more comprehensive overview of the key market players. Additionally, the report also includes significant strategic developments of the market such as partnerships, new product launch, agreements, acquisitions & mergers, research & development collaborations & joint ventures, and growth of major market players on a global and regional basis.

Top Key Players Mentioned in this Report
Gore
Boston Scientific
FierceBiotech
Medtronic
C.R.Bard
Johnson& Johnson

Global PVD Medical Device Market Report 2019 – Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global PVD Medical Device industry.

The key insights of the report:
1.The report provides key statistics on the market status of the PVD Medical Device manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
2.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
3.The report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for key vendors.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report estimates 2019-2024 market development trends of PVD Medical Device industry.
6.Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
7.The report makes some important proposals for a new project of PVD Medical Device Industry before evaluating its feasibility.

View Detailed research report @ https://www.wiseguyreports.com/reports/4381483-global-pvd-medical-device-market-report-2019-market

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

Ebstein’s Anomaly 2019 Global Market Outlook,Research,Trends and Forecast to 2023

WiseGuyReports.Com Publish a New Market Research Report On –“ Ebstein’s Anomaly 2019 Global Market Outlook,Research,Trends and Forecast to 2023”.

PUNE, INDIA, August 30, 2019 /EINPresswire.com/ —

Ebstein’s Anomaly Industry 2019

Description:-

A rare congenital disease, Ebstein's anomaly occurs due to improper development of the tricuspid valve in the first eight weeks of foetal growth. A disorder that occurs when the tricuspid valve that divides the two chambers of the right side of the heart does not form correctly. Driven by an increasing number of congenital heart diseases and rising population, Ebstein’s Anomaly is also caused by factors such as genetics and the environment. Technological advancements and growing number of market players have increased the scope of Ebstein’s anomaly market.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3800448-ebstein-s-anomaly-market-research-report-forecast-to-2023

For more information or any query mail at sales@wiseguyreports.com

Globally, the Ebstein’s anomaly market is expected to grow at a CAGR of around 9.0% during the forecast period. This report analyzes the global Ebstein’s anomaly market by treatment (medication, and surgical treatment) diagnosis (echocardiogram, electrocardiogram, chest x-ray, cardiac MRI, Holter monitor) end-users (hospitals & clinics, and specialty clinics); it also studies the top manufacturers in the market.

Market Segmentation
The global Ebstein’s Anomaly market is segmented on the basis of treatment, diagnosis and end users. On the basis of treatment, the global Ebstein’s anomaly market has been categorized into Medication and Surgical Treatment. When categorized on the basis of diagnosis, the market has been categorized into Echocardiogram, Electrocardiogram, Chest X-Ray, Cardiac MRI and Holter Monitor. Basis end-users, this market has been divided in to Hospitals & Clinics and Specialty Clinics.

Regional Analysis
North America Ebstein’s Anomaly market is rapidly growing in the American region. On a regional basis, the Americas is segmented into North America and South America. North America is segmented into the U.S. and Canada. According to CDC (Centre for Disease Control), it was estimated that about 1 million U.S. children and about 1.4 million U.S. adults were living with CHDs. Additionally, CHDs affect nearly 1% of―or about 40,000―births per year in the United States.
Europe is the second largest market and holds a healthy share in the global Ebstein’s Anomaly market. The European market is expected to steadily grow during the forecast period owing to the skilled professionals and availability of accessible and advanced treatment facilities.

Asia Pacific is expected to be the fastest growing market. India is the fastest growing region owing to the increasing population.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities.

Some of the key players in Ebstein’s Anomaly Market are Ebstein’s Anomaly market are Abbott Vascular, Boston Scientific Corporation, Cordis Corporation, Edwards Lifesciences, Ge Healthcare, Gore Medical, Medtronic, Inc., Numed, Inc., Siemens Healthcare, St. Jude Medical, and Toshiba Corporation among others.

Industry News
Increasing prevalence of chronic diseases such as diabetes is the major driver for the market growth. Rising awareness about the health and availability of new treatment methods drive the market in this region. Rising healthcare expenditure and overall growth of healthcare diagnostic and treatment industry also drives the market. Additionally, wide research and development activities for the treatment of rare disease and increasing government funding also boosts the market growth globally.

Complete Report Details @ https://www.wiseguyreports.com/reports/3800448-ebstein-s-anomaly-market-research-report-forecast-to-2023

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
646 845 9349 / +44 208 133 9349
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}


Source: EIN Presswire

West Virginia Mesothelioma Victims Center Now Urges A Person in West Virginia With Mesothelioma to Call Them For Direct Access To Attorney Erik Karst of Karst von Oiste-No Nonsense Better Compensation Results

The West Virginia Mesothelioma Victims Center is an advocate for people with mesothelioma in and they do not want a person with mesothelioma to get overcharged by lawyers as far as legal fees.”

— West Virginia Mesothelioma Victims Center

WHEELING , WEST VIRGINIA, USA, August 30, 2019 /EINPresswire.com/ — The West Virginia Mesothelioma Victims Center says, "We want a person with mesothelioma in West Virginia or their family members to call us anytime at 800-714-0303 so we briefly explain the financial compensation process and explain why it is so important to get organized when it comes to how, where and when the person was exposed to asbestos. It is this information that is the foundation for a mesothelioma compensation claim and it is vital. We can help a person with mesothelioma organize this information-and we want to emphasize our service is free.

"At some point early on we would also like to introduce a person with mesothelioma in West Virginia to attorney Erik Karst the founding partner of the law firm of Karst von Oiste. The law firm of Karst von Oiste is one of the nation's top mesothelioma law firms and they consistently get the best financial compensation results for their clients.

"We offer direct access to attorney Erik Karst to a person with mesothelioma in West Virginia if they would call us anytime at 800-714-0303. Once we have a little basic information-we will text Erik and he will call you right back." https://WestVirginia.MesotheliomaVictimsCenter.Com

The West Virginia Mesothelioma Victims Center is an advocate for people with mesothelioma in West Virginia and they do not want a person with mesothelioma to get overcharged by unscrupulous lawyers as far as legal fees as they would be happy to discuss anytime at 800-714-0303. https://WestVirginia.MesotheliomaVictimsCenter.Com

Please don't shortchange yourself or your family member by not selecting the nation's most skilled and experienced mesothelioma attorneys if you have been diagnosed with this rare form of cancer anywhere in West Virginia-including-Wheeling, Morgantown, Martinsburg, Charleston, Huntington, and Fairmont."
www.karstvonoiste.com/

The West Virginia Mesothelioma Victims Center is also incredibly focused on making certain a diagnosed victim in the Mountain State has the best treatment options. Two of the better options for diagnosed victims in West Virginia include the Mary Babb Randolph Cancer Center in Morgantown, or the University of Pittsburgh's Cancer Institute:

* The Mary Babb Randolph Cancer Center Morgantown, West Virginia: http://www. wvucancer.org/.#sthash. lf6xcXiQ.dpuf

* The University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania: https://upci. upmc.edu/

The states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. www.karstvonoiste.com/

High-risk work groups for exposure to asbestos in West Virginia include US Navy Veterans, power plant workers, shipyard workers, oil refinery workers, steel mill workers, coal miners, manufacturing, or industrial workers, plumbers, electricians, auto mechanics, machinists, miners, or construction workers. Typically, the exposure to asbestos occurred in the 1950's, 1960's, 1970's, or 1980's. https://WestVirginia.MesotheliomaVictimsCenter.Com

For more information about mesothelioma please refer to the National Institutes of Health's web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma.

For more information about asbestos exposure lung cancer and mesothelioma please visit the CDC's website on these topics: https://www.atsdr.cdc.gov/asbestos/health_effects_asbestos.html.

Michael Thomas
West Virginia Mesothelioma Victims Center
+1 800-714-0303
email us here


Source: EIN Presswire

Virginia US Navy Veterans Mesothelioma Advocate Urges A Navy Veteran with Mesothelioma Nationwide To Call Them for Instant Access to Attorney Erik Karst of Karst von Oiste-Norfolk Veterans Deserve Better Compensation

"If you are a Navy Veteran and you have recently been diagnosed with mesothelioma or their family please call us anytime at 800-714-0303. We offer some vital services and our services are free.”

— Virginia US Navy Veterans Mesothelioma Advocate

NORFOLK, VIRGINIA, USA, August 30, 2019 /EINPresswire.com/ — The Virginia US Navy Veterans Mesothelioma Advocate says, "Our number one priority is seeing to it that a Navy Veteran with mesothelioma receives the best possible financial compensation-especially if the Navy Veteran's primary exposure to asbestos occurred at Norfolk, Virginia. Norfolk is the home of the world's largest navy base and it's been that way for a long time.

"If you are a Navy Veteran and you have recently been diagnosed with mesothelioma or their family members please call us anytime at 800-714-0303. We offer some incredibly vital services and our services are free." https://Virginia.USNavyMesothelioma.com

The Virginia US Navy Veterans Mesothelioma Advocate offers the following free services:

* Assistance in creating what is called the 'list' that documents a Navy Veteran's exposure to asbestos. Documenting how, where and when a Navy Veteran was exposed to asbestos is the basis for a mesothelioma compensation claim and the group will help a Veteran with mesothelioma to develop this very important information as they would like to discuss anytime at 800-714-0303.

* The group offers direct access to famed mesothelioma attorney Erik Karst of the law firm of Karst von Oiste who will explain the compensation process and provide an assessment of what the Navy Veteran's settlement could be worth.

* The group will assist a Navy Veteran with mesothelioma or asbestos exposure lung cancer to get VA disability benefits.

* "Before a Navy Veteran with mesothelioma in Virginia or nationwide hires a lawyer to assist with a mesothelioma compensation claim please call us at 800-714-0303." https://Virginia.USNavyMesothelioma.Com

The US Navy Veterans Mesothelioma Advocate's services are available to US Navy Veterans with mesothelioma in Norfolk, Virginia Beach, Chesapeake, Arlington, Richmond, Newport News, Hampton, Roanoke, Portsmouth or anywhere in Virginia. www.karstvonoiste.com/

For the best possible mesothelioma treatment options in Virginia the Virginia US Navy Veterans Mesothelioma Advocate strongly recommends the following heath care facilities with the offer to help a diagnosed victim, or their family get to the right physicians at each hospital.

* Massey Cancer Center Richmond, Virginia: https://www.massey.vcu.edu/

* University of Virginia Cancer Center Charlottesville,Virginia: https://cancer.uvahealth.com/

Every US Navy ship vessel built up to 1980 contained asbestos. Extreme exposure to asbestos may have occurred to US Navy Veterans if they were assigned to a navy ship’s engine room, as a machinists mate, electrician, plumber/pipefitter, mechanic, in engineering, as a repair crew member, as a crew member on a nuclear submarine or as a member of the Navy Seabees. Additionally, a US Navy Veteran could have received extreme exposure to asbestos if they were required to stay on their ship or submarine for a major repair, overhaul or retrofit at a shipyard. Asbestos exposure was so extreme on US Navy ships and submarines, about one third of all US citizens diagnosed with mesothelioma each year are Veterans of the US Navy. https://USNavyMesothelioma.Com

The states with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. www.karstvonoiste.com/

For a listing of various classes of US Navy ships or submarines please visit the US Navy website on this topic: https://www.navy.mil/navydata/our_ships.asp.

For more information about mesothelioma please refer to the National Institutes of Health's web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Michael Thomas
Virginia US Navy Veterans Mesothelioma Advocate
+1 800-714-0303
email us here


Source: EIN Presswire